Back

Renalytix stock rises 7% after UBS lifts voting stake to 6.62%

Verifying
  • Renalytix PLC shares rose after UBS increased its voting rights stake.
  • UBS raised its stake from 5.17% to 6.62%.
  • CEO James McCullough bought 340 American Depositary Shares, equivalent to 17,000 ordinary shares.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.